Norges Bank’s Bristol-Myers Squibb BMY Stock Holding History

Norges Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-36,100,698	Closed	-$1.95B	–	202
2025 Q4	$1.95B	Buy	+36,100,698	New	+$1.74B	0.21%	88
2025 Q3	–	Sell	-33,574,290	Closed	-$1.55B	–	228
2025 Q2	$1.55B	Buy	33,574,290 +191,785	+0.6%	+$9.41M	0.19%	98
2025 Q1	$2.04B	Sell	33,382,505 -1,792,973	-5%	-$105M	0.29%	62
2024 Q4	$1.99B	Buy	35,175,478 +794,585	+2%	+$44.4M	0.26%	61
2024 Q3	$1.78B	Buy	34,380,893 +1,786,477	+5%	+$83.8M	0.25%	73
2024 Q2	$1.35B	Buy	32,594,416 +342,256	+1%	+$15.3M	0.2%	90
2024 Q1	$1.75B	Buy	32,252,160 +1,838,521	+6%	+$93.7M	0.28%	65
2023 Q4	$1.56B	Buy	30,413,639 +2,592,589	+9%	+$136M	0.27%	67
2023 Q3	$1.61B	Buy	27,821,050 +310,082	+1%	+$19M	0.33%	51
2023 Q2	$1.76B	Buy	27,510,968 +129,892	+0.5%	+$8.71M	0.35%	47
2023 Q1	$1.9B	Buy	27,381,076 +1,339,432	+5%	+$94.5M	0.42%	45
2022 Q4	$1.87B	Buy	26,041,644 +2,179,873	+9%	+$164M	0.45%	41
2022 Q3	$1.7B	Buy	23,861,771 +3,649,125	+18%	+$265M	0.45%	39
2022 Q2	$1.56B	Buy	20,212,646 +1,131,838	+6%	+$86.2M	0.4%	47
2022 Q1	$1.39B	Sell	19,080,808 -3,597,010	-16%	-$242M	0.3%	64
2021 Q4	$1.41B	Sell	22,677,818 -372,517	-2%	-$21.9M	0.29%	66
2021 Q3	$1.36B	Sell	23,050,335 -730,520	-3%	-$48.1M	0.3%	61
2021 Q2	$1.59B	Sell	23,780,855 -1,332,893	-5%	-$86.9M	0.34%	56
2021 Q1	$1.59B	Buy	25,113,748 +646,446	+3%	+$40.2M	0.36%	54
2020 Q4	$1.52B	Buy	24,467,302 +1,845,747	+8%	+$113M	0.35%	56
2020 Q3	$1.36B	Buy	22,621,555 +10,233	+0%	+$616K	0.36%	53
2020 Q2	$1.33B	Sell	22,611,322 -4,670,591	-17%	-$279M	0.38%	52
2020 Q1	$1.52B	Buy	27,281,913 +219,781	+0.8%	+$13.4M	0.54%	33
2019 Q4	$1.74B	Buy	27,062,132 +9,296,849	+52%	+$532M	0.48%	36
2019 Q3	$901M	Buy	17,765,283 +613,358	+4%	+$28.8M	0.28%	66
2019 Q2	$778M	Buy	17,151,925 +12,733	+0.1%	+$593K	0.24%	75
2019 Q1	$818M	Buy	17,139,192 +1,805,624	+12%	+$89.9M	0.26%	70
2018 Q4	$797M	Buy	15,333,568 +159,936	+1%	+$8.59M	0.3%	66
2018 Q3	$942M	Buy	15,173,632 +49,401	+0.3%	+$2.93M	0.31%	62
2018 Q2	$837M	Buy	15,124,231 +47,654	+0.3%	+$2.57M	0.29%	64
2018 Q1	$954M	Buy	15,076,577 +221,754	+1%	+$14.3M	0.35%	55
2017 Q4	$910M	Hold	14,854,823	–	–	0.33%	53
2017 Q3	$947M	Hold	14,854,823	–	–	0.36%	50
2017 Q2	$828M	Buy	14,854,823 +580,424	+4%	+$31.6M	0.33%	53
2017 Q1	$776M	Buy	14,274,399 +1,093,057	+8%	+$60M	0.32%	59
2016 Q4	$770M	Buy	13,181,342 +109,294	+0.8%	+$5.98M	0.34%	50
2016 Q3	$673M	Buy	13,072,048 +466,268	+4%	+$30M	0.32%	58
2016 Q2	$927M	Sell	12,605,780 -60,697	-0.5%	-$4.29M	0.44%	44
2016 Q1	$809M	Sell	12,666,477 -52,541	-0.4%	-$3.31M	0.4%	47
2015 Q4	$875M	Buy	12,719,018 +247,481	+2%	+$16.4M	0.44%	44
2015 Q3	$738M	Buy	12,471,537 +136,657	+1%	+$8.67M	0.39%	51
2015 Q2	$821M	Sell	12,334,880 -153,893	-1%	-$10.1M	0.41%	45
2015 Q1	$806M	Buy	12,488,773 +13,152	+0.1%	+$823K	0.39%	47
2014 Q4	$736M	Buy	12,475,621 +400,267	+3%	+$22.6M	0.37%	49
2014 Q3	$618M	Sell	12,075,354 -12,075,354	-50%	-$603M	0.33%	55
2014 Q2	$1.17B	Buy	24,150,708 +12,055,245	+100%	+$594M	0.32%	61
2014 Q1	$628M	Buy	12,095,463 +150,000	+1%	+$7.98M	0.35%	52
2013 Q4	$635M	Sell	11,945,463 -1,365,809	-10%	-$69.6M	0.37%	52
2013 Q3	$616M	Sell	13,311,272 -186,611	-1%	-$8.19M	0.36%	53
2013 Q2	$603M	Buy	+13,497,883	New	+$586M	0.37%	47

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank's BMY Position: Q1 2026 in Review

Norges Bank sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 36,100,698 shares — an estimated $1.95B sold.

Norges Bank first reported a position in BMY in Q2 2013 and held it in 50 quarters. The position peaked at $2.04B in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Norges Bank reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 36,100,698 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.95B.
Norges Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 50 quarters.
Norges Bank's Bristol-Myers Squibb position peaked at $2.04B in Q1 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.